DiaMedica Therapeutics Inc. (DMAC) PT Lowered to $14 at Lake Street Capital Markets
Tweet
Share
E-mailGet Alerts DMAC Hot Sheet
Price: $6.75 -1.32%
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Lake Street Capital Markets analyst Thomas Flaten lowered the price target on DiaMedica Therapeutics Inc. (NASDAQ: DMAC) to $14.00 (from $21.00) while maintaining a Buy rating.
Despite the lower price target, the analyst noted positive momentum in the stroke study.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- Legence Corp (LGN) PT Lowered to $100 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
